X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51) 51
index medicus (43) 43
female (32) 32
male (32) 32
middle aged (26) 26
adult (25) 25
life sciences (25) 25
respiratory system (20) 20
aged (19) 19
prognosis (17) 17
pulmonary hypertension (11) 11
[sdv]life sciences [q-bio] (10) 10
abridged index medicus (10) 10
cardiac & cardiovascular systems (10) 10
prospective studies (10) 10
treatment outcome (10) 10
diagnosis (9) 9
oncology (9) 9
retrospective studies (9) 9
carcinoma, non-small-cell lung - drug therapy (8) 8
follow-up studies (8) 8
hypertension, pulmonary - drug therapy (8) 8
lung neoplasms - drug therapy (8) 8
survival (8) 8
cancer (7) 7
care and treatment (7) 7
human health and pathology (7) 7
lung neoplasms - mortality (7) 7
[ sdv ] life sciences [q-bio] (6) 6
aged, 80 and over (6) 6
antineoplastic agents - therapeutic use (6) 6
apoptosis (6) 6
cardiovascular (6) 6
chemotherapy (6) 6
france (6) 6
heart (6) 6
hypertension (6) 6
lung neoplasms - genetics (6) 6
lung neoplasms - pathology (6) 6
medicine, general & internal (6) 6
research (6) 6
risk factors (6) 6
survival analysis (6) 6
carcinoma, non-small-cell lung - mortality (5) 5
drug therapy (5) 5
hypertension, pulmonary - physiopathology (5) 5
medicine (5) 5
mutation (5) 5
patients (5) 5
protein kinase inhibitors - therapeutic use (5) 5
severity of illness index (5) 5
tuberculosis (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
[sdv.can]life sciences [q-bio]/cancer (4) 4
[sdv.mhep.psr]life sciences [q-bio]/human health and pathology/pulmonology and respiratory tract (4) 4
adolescent (4) 4
antihypertensive agents - administration & dosage (4) 4
arterial-hypertension (4) 4
biomarkers, tumor - genetics (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
cardiac catheterization (4) 4
critical care medicine (4) 4
dna methylation (4) 4
france - epidemiology (4) 4
hypertension, pulmonary - diagnosis (4) 4
hypertension, pulmonary - etiology (4) 4
infectious diseases (4) 4
lung cancer (4) 4
lung neoplasms - metabolism (4) 4
management (4) 4
medical prognosis (4) 4
mortality (4) 4
neoadjuvant therapy (4) 4
neoplasm staging (4) 4
pulmonology and respiratory tract (4) 4
registries (4) 4
transplantation (4) 4
tumor suppressor proteins - genetics (4) 4
young adult (4) 4
adjuvant chemotherapy (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
biomarkers, tumor - metabolism (3) 3
biopsy (3) 3
bosentan (3) 3
bronchoalveolar lavage (3) 3
carcinoma, non-small-cell lung - metabolism (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
cardiology (3) 3
cisplatin (3) 3
combination therapy (3) 3
complications and side effects (3) 3
cystic fibrosis (3) 3
cystic fibrosis - diagnostic imaging (3) 3
cystic fibrosis - physiopathology (3) 3
diagnosis, differential (3) 3
doppler-echocardiography (3) 3
ecology, environment (3) 3
epoprostenol (3) 3
epoprostenol - administration & dosage (3) 3
familial primary pulmonary hypertension (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 167, Issue 2, pp. 210 - 217
Journal Article
European Respiratory Journal, ISSN 0903-1936, 08/2017, Volume 50, Issue 2, pp. 1700889 - 1700889
Journal Article
Revue du Praticien, ISSN 0035-2640, 10/2011, Volume 61, Issue 8, pp. 1064 - 1070
Journal Article
Journal Article
La Revue du praticien, ISSN 0035-2640, 10/2011, Volume 61, Issue 8, p. 1064
Journal Article
Journal Article
The European respiratory journal, ISSN 0903-1936, 10/2017, Volume 50, Issue 4, pp. 1700465 - 1700465
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2015, Volume 34, Issue 4, pp. 538 - 546
Journal Article
Circulation, ISSN 0009-7322, 05/2012, Volume 125, Issue 17, pp. 2128 - 2137
Background-The French pulmonary hypertension (PH) registry allows the survey of epidemiological trends. Isolated cases of precapillary PH have been reported in... 
Dasatinib | Chronic myeloid leukemia | Vascular complications | Adverse drug events | Pulmonary hypertension | CHRONIC MYELOGENOUS LEUKEMIA | LONG-TERM | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | MYELOPROLIFERATIVE DISORDERS | INHIBITORS IMATINIB | pulmonary hypertension | TYROSINE KINASE | CELL-GROWTH | FAILURE | NILOTINIB | CHRONIC MYELOID-LEUKEMIA | adverse drug events | vascular complications | dasatinib | chronic myeloid leukemia | PERIPHERAL VASCULAR DISEASE | Hypertension, Pulmonary - diagnosis | Follow-Up Studies | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Thiazoles - therapeutic use | Hypertension, Pulmonary - chemically induced | Thiazoles - adverse effects | Antineoplastic Agents - adverse effects | Adult | Female | Registries | Antineoplastic Agents - pharmacology | Hypertension, Pulmonary - drug therapy | Drug Utilization - statistics & numerical data | Endothelin Receptor Antagonists | Bone Morphogenetic Protein Receptors, Type II - genetics | Adverse Drug Reaction Reporting Systems | Treatment Outcome | Piperazines - therapeutic use | Hypertension, Pulmonary - epidemiology | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - adverse effects | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Pyrimidines - adverse effects | Hydroxyurea - therapeutic use | Aged | Hemodynamics - drug effects | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Benzamides | Care and treatment | Dosage and administration | Drug therapy | Life Sciences | Biochemistry, Molecular Biology
Journal Article